Enhanced In Vitro/In Vivo Cytotoxicity Against Burkitt Lymphoma/Primary Mediastinal Large B Cell Lymphoma by Polatuzumab Vedotin (hu- anti-CD79b-vc-MMAE, PV) Alone or in Combination with Obinutuzumab

Author Type(s)

Faculty, Resident/Fellow

Document Type

Abstract

Publication Date

7-2018

DOI

10.1158/1538-7445.AM2018-1788

Journal Title

Cancer Research

Department

Pediatrics

Second Department

Health Behavior and Community Health

This document is currently not available here.

Share

COinS